QP 47 - Research Highlights from Around the Globe

Presentations

• 09:17am - 09:23am ET

  Clinical Outcomes of Reduced-Dose Whole-Brain Radiotherapy After Induction Chemotherapy for Primary Central Nervous System Lymphoma: A Retrospective Single-Institution Study

  Speaker: Hiroaki Ogawa, MD - Miyagi Cancer Center, Miyagi
• 09:23am - 09:29am ET

  The Impact of Radiotherapy Quality on Patient Outcomes in Pediatric Multicenter Clinical Trials: A Systematic Review and Meta-Analysis

  Speaker: Vaishvi Patel, MD - Cross Cancer Institute, Edmonton
• 09:29am - 09:35am ET

  Internally Validated Survival Nomograms for Recurrence, Metastasis, and Overall Survival after Salvage Prostate Brachytherapy

  Speaker: Mateusz Bilski, MD, PhD - Lublin Region Oncology Center, Lublin
• 09:35am - 09:41am ET

  WGS-Based Personalized ctDNA Assay for Molecular Residual Disease (MRD) Detection in Locally Advanced Cervical Cancer Treated with Definitive Chemoradiotherapy: Interim Results from a Prospective Multicenter Study (MONSTAR-SCREEN-3)

  Speaker: Masaki Nakamura, MD - National Cancer Center Hospital East, Kashiwa
• 09:41am - 09:47am ET

  Radiation Dose Optimization in Reirradiation for Recurrent Glioblastoma: Results of the Multicenter KROG 21-02 Study

  Speaker: Chan Woo Wee, MD, PhD - Yonsei Cancer Center, Yonsei University College of Medicine, Seoul
• 09:47am - 09:53am ET

  Patterns of Care and Treatment-Related Complications Following Breast Reconstruction after Mastectomy for Breast Cancers (KROG 24-06 Study)

  Speaker: In Ah Kim, MD, PhD - Seoul National University Bundang Hospital, Seongnamsi
• 09:53am - 09:59am ET

  Large-Scale Real-World Implementation of Risk-Adapted Ultra-Hypofractionated Whole-Breast Irradiation in Early-Stage Breast Cancer

  Speaker: Olga Unterkirhere, MD, DO, DSc, PhD - Luzerner Kantonsspital (LUKS), Lucerne